ORKA
NASDAQ · Biotechnology
Oruka Therapeutics Inc
$38.91
+0.09 (+0.23%)
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Price Target
Analyst Price Target
-46.8% upside
Low Target
$16.39
Average Target
$20.70
High Target
$27.30
Current Price
$38.91
Current
$38.91
$38.91
Target
$20.70
$20.70
$16.39
$20.70 avg
$27.30
Scenario Analysis
Bear Case
$16.39
-57.9%
Low target
Base Case
$20.70
-46.8%
Avg target
Bull Case
$27.30
+-29.8%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$36.51
6.6% from high
52-Week Low
$5.49
+609.4% from low
Target vs 52W High
$20.70
-43.3% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +24.3% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.3% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.7% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.8% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |